Clinical Trials in Salt Lake City

Showing 5441-5460 of 16,694 trials

IMPACT Study: IMProve Pregnancy in APS With Certolizumab Therapy

NCT03152058

This treatment trial evaluates the addition of an anti-tumor necrosis factor-alpha drug, certolizumab, to usual treatment (a heparin agent and low-dose aspirin) in pregnant women with antiphospholipid syndrome (APS) and repeatedly positive tests for lupus anticoagulant (LAC) to determine if this regimen will improve pregnancy outcomes. All enrolled patients will receive certolizumab, and pregnancy outcomes will be compared to those of women with APS and repeatedly positive tests for LAC enrolled in a previous study by the investigators.

High Risk PregnancyPregnancy ComplicationsAntiphospholipid Syndrome in Pregnancy+1 more

David Ware Branch55 participantsStarted May 2017

New York, New York, United States • Salt Lake City, Utah, United States • Toronto, Ontario, Canada

COMPLETEDNA< 1 mile

De-Implementation of Unnecessary Surgical Antibiotic Prophylaxis in Children

NCT04366440

The overall objective of this study is to identify the best strategy to eliminate unnecessary antibiotic use after surgery in pediatric surgical procedures considered low-risk for an SSI. Based on literature and our preliminary data suggesting surgeons will not fully accept standardized order sets based on current guidelines, the investigators hypothesize that order set modification combined with ASP facilitation will outperform standard order set modification alone in de-implementing unnecessary postoperative antibiotic use.

Surgical Site Infection

Washington University School of Medicine39,363 participantsStarted Nov 2020

St. Petersburg, Florida, United States • Boston, Massachusetts, United States • Ann Arbor, Michigan, United States +7 more locations

IMPACT Study: IMProve Pregnancy in APS With Certolizumab Therapy

De-Implementation of Unnecessary Surgical Antibiotic Prophylaxis in Children

Find Trials by Condition in Salt Lake City

Exercise Timing in Breast Cancer Patients

Implications for Management of PET Amyloid Classification Technology in the Imaging Dementia(IDEAS) Trial

A Study of ASP8273 vs. Erlotinib or Gefitinib in First-line Treatment of Patients With Stage IIIB/IV Non-small Cell Lung Cancer Tumors With EGFR Activating Mutations

SpineJack System Postmarket Registry

Phase 1b, Open-Label Study to Evaluate the Safety, Tolerability, and Pharmacodynamics of EP262 in Subjects With Chronic Inducible Urticaria

Feasibility and ML Training Investigation of the Senseye DT for Diagnosis of Adults with PTSD

Repertaxin in Prevention of Primary Graft Dysfunction After Lung Transplantation

Assessment of Safety of the Use of Fenfluramine in Children With Dravet Syndrome Under 24 Months of Age

Pragmatic Trial Examining Oxygenation Prior to Intubation

Safety and Efficacy Study of IMSA101 in Refractory Malignancies

ET-01 in Subjects With Lateral Canthal Lines, LCL-210

Osia 2 Pediatric Expansion Study

Efficacy and Safety of MK-1942 as an Adjunct Therapy in Participants With Mild to Moderate Alzheimer's Disease Dementia (MK-1942-008)

A Study to Investigate the Prevention of COVID-19 WithVYD222 in Adults with Immune Compromise and in Participants Aged 12 Years or Older Who Are At Risk of Exposure to SARS-CoV-2

realMIND: Observational Study on Safety and Effectiveness of Tafasitamab in Combination With Lenalidomide in Patients With Relapsed or Refractory DLBCL

Study Evaluating the Efficacy and Safety of OCS-01 Eye Drops in Subjects Following Cataract Surgery

Motion Syros: A Study to Investigate the Efficacy of Tradipitant in Subjects Affected by Motion Sickness

A Study of Bispecific Antibody MCLA-145 in Patients With Advanced or Metastatic Malignancies